80027148: Addressing the Challenges in Risk Assessment and Risk Management in Multiple Sclerosis

Please go to course content

Presented by: The Johns Hopkins University School of Medicine

Release Date: December 21, 2011
Expiration Date: December 21, 2012

Acknowledgement of Commercial Support: Supported by an educational grant from Biogen Idec

A new era of MS therapeutics is upon us. The list of FDA approved therapies is not just expected to increase in size over the next three years, but the agents on the list will expand in complexity - each with a novel mechanism of action, benefit profile and risk potential. Neurologists treating MS patients are anxious to formulate protocols for initiating the ‘right’ therapy for the ‘right’ patient while balancing benefit and risk. To do this, a thorough understanding of the various risk potentials and risk mitigation strategies is essential

After viewing the program, the participant should demonstrate the ability to:

• Describe the key data to consider in the assessment and management of risk of MS therapies
• Discuss the balance required in managing the risk of MS itself and the risk of therapies to treat MS
• Assess current practice of risk/benefit assessment in light of proposed alternatives
• Describe a model for the assessment of risk and risk management of MS therapies
• Outline the issues to consider in the prioritization of data in conducting a risk/benefit assessment

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Policy On Speaker And Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the activity handout materials.